Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1273, 2009-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA warns of increased myopathy risk with Zocor
Reactions Weekly, Vol. 1, Iss. 1294, 2010-01 ,pp. :
Access to resources
Recommend
US FDA strengthens isotretinoin risk management programme
Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. :
US FDA issues early communication about Xigris safety
Reactions Weekly, Vol. 1, Iss. 1239, 2009-01 ,pp. :
Oral sodium phosphates: acute renal failure risk, warns US FDA
Reactions Weekly, Vol. 1, Iss. 1101, 2006-01 ,pp. :
US FDA advises of risk factor for PML, gives go ahead for test
Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. :